|
|
||||||||

*
Immunologie Cellulaire, Laboratoire de Biologie Moléculaire et Cellulaire, Ecole Normale Supérieure de Lyon Centre National de la Recherche Scientifique, Lyon, France; and
Laboratoire de Physiologie Animale, Université Libre de Bruxelles, Brussels, Belgium
The mechanisms responsible for peripheral CD8 T cell tolerance to
foreign Ags remain poorly understood. In this study we have
characterized the state of CD8 T cell tolerance induced in F5
TCR transgenic mice by multiple peptide injections in vivo. The
tolerant state of CD8 T cells is characterized by impaired
proliferative responses, increased sensitivity to cell death, and
failure to acquire cytotoxic effector function after in vitro antigenic
challenge. In vivo monitoring of CD8 T cell proliferation using
5-carboxyfluorescein diacetate succinimidyl ester showed that a large
subset of the tolerant T cell population failed to divide in response
to peptide. TCR down-regulation could not account for this loss of
responsiveness to Ag since recombination-activating gene-1
(RAG-1)-/-F5 CD8 T cell responses were similar to
those of RAG-1-/-F5 x RAG-1-/-
F1 T lymphocytes, which express lower levels of the
transgenic TCR. Analysis of early signal transduction in tolerant CD8 T
cells revealed high basal levels of cytoplasmic calcium as well as
impaired calcium mobilization and tyrosine phosphorylation after
cross-linking of CD3
and CD8
. Together these data indicate that
repeated exposure to soluble antigenic peptide in vivo can induce a
state of functional tolerance characterized by defective TCR signaling,
impaired proliferation, and increased sensitivity to cell
death.
This article has been cited by other articles:
![]() |
C. D. Hammerbeck and M. F. Mescher Antigen Controls IL-7R{alpha} Expression Levels on CD8 T Cells during Full Activation or Tolerance Induction J. Immunol., February 15, 2008; 180(4): 2107 - 2116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Srinivasan and K. A. Frauwirth Reciprocal NFAT1 and NFAT2 Nuclear Localization in CD8+ Anergic T Cells Is Regulated by Suboptimal Calcium Signaling J. Immunol., September 15, 2007; 179(6): 3734 - 3741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pihlgren, M. Friedli, C. Tougne, A.-F. Rochat, P.-H. Lambert, and C.-A. Siegrist Reduced Ability of Neonatal and Early-Life Bone Marrow Stromal Cells to Support Plasmablast Survival J. Immunol., January 1, 2006; 176(1): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ise, K. Nakamura, N. Shimizu, H. Goto, K. Fujimoto, S. Kaminogawa, and S. Hachimura Orally Tolerized T Cells Can Form Conjugates with APCs but Are Defective in Immunological Synapse Formation J. Immunol., July 15, 2005; 175(2): 829 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Redmond, B. C. Marincek, and L. A. Sherman Distinct Requirements for Deletion versus Anergy during CD8 T Cell Peripheral Tolerance In Vivo J. Immunol., February 15, 2005; 174(4): 2046 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mitchell and B. P. Lawrence Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Renders Influenza Virus-Specific CD8+ T Cells Hyporesponsive to Antigen Toxicol. Sci., July 1, 2003; 74(1): 74 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Curtsinger, D. C. Lins, and M. F. Mescher Signal 3 Determines Tolerance versus Full Activation of Naive CD8 T Cells: Dissociating Proliferation and Development of Effector Function J. Exp. Med., May 5, 2003; 197(9): 1141 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asai, S. Hachimura, M. Kimura, T. Toraya, M. Yamashita, T. Nakayama, and S. Kaminogawa T Cell Hyporesponsiveness Induced by Oral Administration of Ovalbumin Is Associated with Impaired NFAT Nuclear Translocation and p27kip1 Degradation J. Immunol., November 1, 2002; 169(9): 4723 - 4731. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ohlen, M. Kalos, L. E. Cheng, A. C. Shur, D. J. Hong, B. D. Carson, N. C.T. Kokot, C. G. Lerner, B. D. Sather, E. S. Huseby, et al. CD8+ T Cell Tolerance to a Tumor-associated Antigen Is Maintained at the Level of Expansion Rather than Effector Function J. Exp. Med., June 3, 2002; 195(11): 1407 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Steinbrink, E. Graulich, S. Kubsch, J. Knop, and A. H. Enk CD4+ and CD8+ anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity Blood, April 1, 2002; 99(7): 2468 - 2476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walzer, C. Arpin, L. Beloeil, and J. Marvel Differential In Vivo Persistence of Two Subsets of Memory Phenotype CD8 T Cells Defined by CD44 and CD122 Expression Levels J. Immunol., March 15, 2002; 168(6): 2704 - 2711. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Arpin, G. Angelov, T. Walzer, M. Tomkowiak, and J. Marvel Hyperproliferative Response of a Monoclonal Memory CD8 T Cell Population Is Characterized by an Increased Frequency of Clonogenic Precursors J. Immunol., March 1, 2002; 168(5): 2147 - 2153. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson CTLA-4 Is Not Required for Induction of CD8+ T Cell Anergy In Vivo J. Immunol., November 1, 2001; 167(9): 4936 - 4941. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Maile, B. Wang, W. Schooler, A. Meyer, E. J. Collins, and J. A. Frelinger Antigen-Specific Modulation of an Immune Response by In Vivo Administration of Soluble MHC Class I Tetramers J. Immunol., October 1, 2001; 167(7): 3708 - 3714. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bercovici, A. Heurtier, C. Vizler, N. Pardigon, C. Cambouris, P. Desreumaux, and R. Liblau Systemic Administration of Agonist Peptide Blocks the Progression of Spontaneous CD8-Mediated Autoimmune Diabetes in Transgenic Mice Without Bystander Damage J. Immunol., July 1, 2000; 165(1): 202 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction J. Immunol., March 15, 2000; 164(6): 2987 - 2993. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. T. Nugent, D. J. Morgan, J. A. Biggs, A. Ko, I. M. Pilip, E. G. Pamer, and L. A. Sherman Characterization of CD8+ T Lymphocytes That Persist After Peripheral Tolerance to a Self Antigen Expressed in the Pancreas J. Immunol., January 1, 2000; 164(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Schmidt and M. F. Mescher Adjuvant Effect of IL-12: Conversion of Peptide Antigen Administration from Tolerizing to Immunizing for CD8+ T Cells In Vivo J. Immunol., September 1, 1999; 163(5): 2561 - 2567. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Blish, S. R. Dillon, A. G. Farr, and P. J. Fink Anergic CD8+ T Cells Can Persist and Function In Vivo J. Immunol., July 1, 1999; 163(1): 155 - 164. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |